Rhabdomyolysis due to Trimethoprim-Sulfamethoxazole Administration following a Hematopoietic Stem Cell Transplant

Table 1

Complete medication and dosing history with relevant laboratory values for our patient during first inpatient admission for rhabdomyolysis (September 9, 2013), discharge (September 12, 2013), and outpatient clinic follow-up visit (September 27, 2013). The same information is also presented for the second inpatient admission for rhabdomyolysis (October 3, 2013), discharge (October 6, 2013), and outpatient clinic follow-up visit (October 14, 2013).

	September 9	September 12	September 27	October 3	October 6	October 14
Medications
Dasatinib	100 mg daily	—	100 mg daily	100 mg daily	100 mg daily	100 mg daily
TMP/SMX	160/800 MWF	—	160/800 MWF	160/800 MWF	—	—
Valacyclovir	500 mg daily	—	—	—	—	500 mg daily
Amlodipine	5 mg daily	—	5 mg daily	5 mg daily	5 mg daily	5 mg daily
Pantoprazole	40 mg daily	—	40 mg daily	40 mg daily	40 mg daily	40 mg daily
Lab values (IU/L)
CK	132,400	43,700	301	34,308	8,329	285
LDH	3,172	—	203	647	—	210
AST	1,532	978	26	535	198	26
ALT	321	351	28	230	149	37